TA

Thomas Abraham

Director Director DIN 08253328
DIN 08253328 First appointment Aug 2018 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Aug 2018
Shareholding value Locked Premium profile

About Thomas Abraham

Data last updated:

Thomas Abraham has 8 years in corporate governance. Formerly with 1 company, such as Essbrains Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08253328
Primary Designation Director
First Appointment 06 Aug 2018
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Essbrains Pharma Private Limited U24233KL2013PTC034952
Director06 Aug 20182013Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Essbrains Pharma Private Limited
Premium access

Shareholding and investment profile for Thomas Abraham

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Thomas Abraham

Thomas Abraham has 8 years in corporate governance. Formerly with 1 company, such as Essbrains Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Thomas Abraham is associated with 0 companies as a director.

Thomas Abraham has expertise in General Business.

Thomas Abraham has 8 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available